Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Equity Average (2020 - 2025)

iSpecimen has reported Equity Average over the past 6 years, most recently at $3.1 million for Q4 2025.

  • For Q4 2025, Equity Average fell 23.23% year-over-year to $3.1 million; the TTM value through Dec 2025 reached $3.1 million, down 23.23%, while the annual FY2025 figure was $3.2 million, 50.97% down from the prior year.
  • Equity Average for Q4 2025 was $3.1 million at iSpecimen, up from $1.8 million in the prior quarter.
  • Over five years, Equity Average peaked at $28.7 million in Q1 2022 and troughed at -$29.2 million in Q1 2021.
  • A 5-year average of $9.3 million and a median of $9.8 million in 2023 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: skyrocketed 357.86% in 2022 and later tumbled 82.25% in 2025.
  • Year by year, Equity Average stood at $20.9 million in 2021, then increased by 2.03% to $21.4 million in 2022, then tumbled by 47.47% to $11.2 million in 2023, then plummeted by 64.25% to $4.0 million in 2024, then decreased by 23.23% to $3.1 million in 2025.
  • Business Quant data shows Equity Average for ISPC at $3.1 million in Q4 2025, $1.8 million in Q3 2025, and $1.1 million in Q2 2025.